文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

预测前列腺癌放疗患者血尿风险的胚系依赖性

Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.
PubMed 文献 · Radiother Oncol · 2023-05-25

研究纳入668例接受放疗的前列腺癌患者,应用预条件随机森林回归(PRFR)分析全基因组胚系单核苷酸多态性(SNP)以分层放疗后血尿风险。PRFR预测性能显著优于其他方法(均P<0.05),验证集中高、低风险组(各占1/3样本)的比值比为2.87(P=0.029)。生物信息学分析识别出6个关键蛋白及4个与膀胱和泌尿道相关的生物学过程网络。

要点

  • PRFR方法预测性能显著优于其他替代方法(均P<0.05)。
  • 验证集高、低风险组(各占1/3样本)比值比为2.87(P=0.029)。
  • 生物信息学分析识别出CTNND2、GSK3B、KCNQ2、NEDD4L、PRKAA1和TXNL1基因编码的6个关键蛋白。

核心结论

  • 血尿风险显著依赖于常见遗传变异。
  • PRFR算法可对前列腺癌患者放疗后血尿风险进行不同风险水平的分层。
  • 生物信息学分析识别出参与放射性血尿的重要生物学过程。

研究设计与样本

  • 研究数据来自668例接受放疗的前列腺癌患者的胚系全基因组SNP。
  • 队列仅在建模过程开始时分层一次,分为训练集(2/3样本)用于建模和验证集(1/3样本)。
  • 应用先前开发的预条件随机森林回归(PRFR)两步机器学习算法,包括预条件步骤产生调整后结局,随后进行随机森林回归建模。
  • 建模后进行生物信息学分析以识别与血尿风险 plausibly 相关的生物学关联。

主要发现

  • PRFR方法与其他替代方法相比取得显著更好的预测性能(均P<0.05)。
  • 验证集中高、低风险组(各由1/3样本组成)之间的比值比为2.87(P=0.029),提示具有临床实用水平的分辨能力。
  • 生物信息学分析识别出CTNND2、GSK3B、KCNQ2、NEDD4L、PRKAA1和TXNL1基因编码的6个关键蛋白。
  • 生物信息学分析识别出4个统计学显著的生物学过程网络,这些网络先前已被证明与膀胱和泌尿道相关。

关键数值与推荐

  • 验证集中高、低风险组(各由1/3样本组成)的比值比为2.87(P=0.029)。
  • PRFR方法与其他替代方法比较均P<0.05。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Late radiation-induced hematuria can develop in prostate cancer patients undergoing radiotherapy and can negatively impact the quality-of-life of survivors. If a genetic component of risk could be modeled, this could potentially be the basis for modifying treatment for high-risk patients. We therefore investigated whether a previously developed machine learning-based modeling method using genome-wide common single nucleotide polymorphisms (SNPs) can stratify patients in terms of the risk of radiation-induced hematuria. MATERIALS AND METHODS: We applied a two-step machine learning algorithm that we previously developed for genome-wide association studies called pre-conditioned random forest regression (PRFR). PRFR includes a pre-conditioning step, producing adjusted outcomes, followed by random forest regression modeling. Data was from germline genome-wide SNPs for 668 prostate cancer patients treated with radiotherapy. The cohort was stratified only once, at the outset of the modeling process, into two groups: a training set (2/3 of samples) for modeling and a validation set (1/3 of samples). Post-modeling bioinformatics analysis was conducted to identify biological correlates plausibly associated with the risk of hematuria. RESULTS: The PRFR method achieved significantly better predictive performance compared to other alternative methods (all p < 0.05). The odds ratio between the high and low risk groups, each of which consisted of 1/3 of samples in the validation set, was 2.87 (p = 0.029), implying a clinically useful level of discrimination. Bioinformatics analysis identified six key proteins encoded by CTNND2, GSK3B, KCNQ2, NEDD4L, PRKAA1, and TXNL1 genes as well as four statistically significant biological process networks previously shown to be associated with the bladder and urinary tract. CONCLUSION: The risk of hematuria is significantly dependent on common genetic variants. The PRFR algorithm resulted in a stratification of prostate cancer patients at differential risk levels of post-radiotherapy hematuria. Bioinformatics analysis identified important biological processes involved in radiation-induced hematuria.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Oh JH, Lee S, Thor M, et al. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients. Radiother Oncol. 2023. PMID: 37244355. doi:10.1016/j.radonc.2023.109723

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。